Drug · DIN 02402017 · Radiopharmaceutical
NAF PLUS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 13, 2018; first marketed April 5, 2013.
- Drug Identification Number (DIN)
- 02402017
- Company (DIN owner)
- Isologic Innovative Radiopharmaceuticals Ltd.Dorval, Quebec, Canada
- Schedule
- Schedule c
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Fludeoxyglucose (18f) V09IX04
- Class
- Radiopharmaceutical
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM FLUORIDE F 18 | 7400 MBq | ML |